FDA Adverse Event Injury Summary report: N

UNK KELLER FUNNEL2

MDR report key: 19601091 · Received June 24, 2024

Report

Report Number
3011299751-2024-00097
Event Type
Injury
Date Received
June 24, 2024
Date of Event
May 12, 2024
Report Date
June 24, 2024
Manufacturer
ALLERGAN (KELLER)
Product Code
KDD
PMA / PMN Number
510(K)EXEMPT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PL
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE REPORTED EVENTS OF INFECTION AND WOUND DEHISCENCE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN/WILL BE REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE REASON FOR REOPERATION IS: "MINOR INFECTION AT THE INCISION SITES AND SUBSEQUENT WOUND DEHISCENCE." ARTICLE CITATION: ELSAFTAWY, AHMED, ET AL. "ENHANCING BUTTOCK CONTOURS: A SAFER APPROACH TO GLUTEAL AUGMENTATION WITH ULTRASONIC LIPOSUCTION, SUBMUSCULAR IMPLANTS, AND ULTRASOUND-GUIDED FAT GRAFTING." J. CLIN. MED. 2024, 13, 2856. HTTPS://DOI.ORG/10.3390/JCM13102856.

Description of Event or Problem · 0

THROUGH JOURNAL ARTICLE "ENHANCING BUTTOCK CONTOURS: A SAFER APPROACH TO GLUTEAL AUGMENTATION WITH ULTRASONIC LIPOSUCTION, SUBMUSCULAR IMPLANTS, AND ULTRASOUND-GUIDED FAT GRAFTING" PATIENT EXPERIENCED A "MINOR INFECTION AT THE INCISION SITES AND SUBSEQUENT WOUND DEHISCENCE." THE SURGICAL PROCEDURE UTILIZED A KELLER-FUNNEL 2 DEVICE. ULTRASOUND-ASSISTED LIPOSUCTION AND ULTRASOUND-GUIDED FAT GRAFTING WERE PERFORMED. TREATMENT INCLUDED ULTRASONIC LIPOSUCTION USING A VASER DEVICE. PAIN MANAGEMENT MEDICATION WAS ADMINISTERED AS PART OF TREATMENT ALONG WITH LYMPHATIC MASSAGES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2101988 UNK KELLER FUNNEL2 KIT, SURGICAL INSTRUMENT, DISPOSABLE KDD ALLERGAN (KELLER) NI

Patients

Seq Age Sex Outcome Treatment
1 34 YR Female Required Intervention